{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:22:53Z","timestamp":1787498573184,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100022974","name":"Global Alliance for Chronic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["ACCI GACD-025"],"award-info":[{"award-number":["ACCI GACD-025"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejca.2023.113389","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:40:55Z","timestamp":1697629255000},"page":"113389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6510-8573","authenticated-orcid":false,"given":"Kari","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Torode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ilbawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Chakowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-2837","authenticated-orcid":false,"given":"Brian","family":"Bourbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Sengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Gralow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-1825","authenticated-orcid":false,"given":"Richard","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2023.113389_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2023.113389_bib2","unstructured":"Cancer Research UKWorldwide cancer statistics [Internet]; 2022. \u3008https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/worldwide-cancer\u3009\u00a0(accessed\u00a0November\u00a018,\u00a02022)."},{"issue":"suppl 15","key":"10.1016\/j.ejca.2023.113389_bib3","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1200\/jco.2010.28.15_suppl.6099","article-title":"Optimal chemotherapy utilization rate in cancer care: setting an evidence-based benchmark for quality improvement","volume":"28","author":"Ng","year":"2010","journal-title":"J Clin Oncol [Internet]"},{"key":"10.1016\/j.ejca.2023.113389_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: current perspectives and new challenges","volume":"13","author":"Pucci","year":"2019","journal-title":"Ecancermedicalscience"},{"issue":"9","key":"10.1016\/j.ejca.2023.113389_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/d41573-022-00095-1","article-title":"Landscape of cancer cell therapies: trends and real-world data","volume":"21","author":"Saez-Iba\u00f1ez","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejca.2023.113389_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"Suppl 2","key":"10.1016\/j.ejca.2023.113389_bib7","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2023.113389_bib8","first-page":"1835","article-title":"Retrospective analysis of mortalities associated with medication errors","volume":"58","author":"Phillips","year":"2001","journal-title":"Am J Health\u00a0Syst\u00a0Pharm"},{"key":"10.1016\/j.ejca.2023.113389_bib9","unstructured":"American Society of Clinical Oncology. ASCO & WHO to Collaborate on Quality Indicators for Cancer Facilities [Internet]; 2022. \u3008https:\/\/old-prod.asco.org\/about-asco\/press-center\/news-releases\/asco-who-collaborate-quality-indicators-cancer-facilities\u3009\u00a0(accessed\u00a0April 17,\u00a02023)."},{"issue":"12","key":"10.1016\/j.ejca.2023.113389_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care. How can it be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2023.113389_bib11","unstructured":"Centers for Medicare & Medicaid Services. Quality Measurement and Quality Improvement; 2021."},{"issue":"1 Suppl","key":"10.1016\/j.ejca.2023.113389_bib12","first-page":"I30","article-title":"Connections between quality measurement and improvement","volume":"41","author":"Berwick","year":"2003","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.ejca.2023.113389_bib13","article-title":"A narrative synthesis of the quality of cancer care and development of an integrated conceptual framework","volume":"27","author":"Chiew","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ejca.2023.113389_bib14","doi-asserted-by":"crossref","first-page":"k1581","DOI":"10.1136\/bmj.k1581","article-title":"Effect of public reporting of surgeons\u2019 outcomes on patient selection, \u201cgaming,\u201d and mortality in colorectal cancer surgery in England: population based cohort study","volume":"361","author":"Vallance","year":"2018","journal-title":"BMJ [Internet]."},{"issue":"9","key":"10.1016\/j.ejca.2023.113389_bib15","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s11605-018-4015-3","article-title":"Combining surgical outcomes and patient experiences to evaluate hospital gastrointestinal cancer surgery quality","volume":"23","author":"Liu","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.ejca.2023.113389_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.33299","article-title":"Variations in surgical spending within hospital systems for complex cancer surgery","volume":"127","author":"Diaz","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.juro.2017.02.3338","article-title":"Repeat prostate biopsy practice patterns in a statewide quality improvement collaborative","volume":"198","author":"Burks","year":"2017","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10549-011-1809-3","article-title":"Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands","volume":"131","author":"van der Heiden-van der Loo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejca.2023.113389_bib19","first-page":"505","article-title":"Variation in lymph node examination after esophagectomy for cancer in the United States","volume":"147","author":"Merkow","year":"2012","journal-title":"Arch Surg [Internet]"},{"issue":"4","key":"10.1016\/j.ejca.2023.113389_bib20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jamcollsurg.2014.03.063","article-title":"Florida initiative for quality cancer care: improvements in breast cancer quality indicators during a 3-year interval","volume":"219","author":"Laronga","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.ejca.2023.113389_bib21","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/S1470-2045(20)30558-1","article-title":"Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit","volume":"22","author":"Aggarwal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113389_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/1754-9485.13373","article-title":"Quality indicators for radiation oncology","volume":"66","author":"Harden","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1200\/JOP.2014.001564","article-title":"A decade of research on the quality of systemic cancer therapy in routine care: what aspects of quality are we measuring?","volume":"11","author":"Shen","year":"2015","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1016\/j.ejca.2023.113389_bib24","article-title":"The development of outcome key performance indicators for systemic anti-cancer therapy using a modified Delphi method","volume":"29","author":"Mellett","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ejca.2023.113389_bib25","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejca.2023.113389_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JOP.2010.000174","article-title":"Degree of variability in performance on breast cancer quality indicators: findings from the florida initiative for quality cancer care","volume":"7","author":"Gray","year":"2011","journal-title":"J Oncol Pract"},{"issue":"3","key":"10.1016\/j.ejca.2023.113389_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jtcvs.2020.05.123","article-title":"Institutional factors associated with adherence to quality measures for stage I and II non\u2013small cell lung cancer","volume":"162","author":"Khorfan","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bmjqs-2019-009742","article-title":"Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?","volume":"29","author":"Ellis","year":"2020","journal-title":"BMJ Qual Saf [Internet]"},{"issue":"6","key":"10.1016\/j.ejca.2023.113389_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1159\/000513523","article-title":"Uyl-de Groot CA, van Erkelens JA, Wakkee M, Nijsten TEC. Practice variation in skin cancer treatment and follow-up care: a Dutch claims database analysis","volume":"237","author":"van Egmond","year":"2021","journal-title":"Dermatology [Internet]"},{"issue":"3","key":"10.1016\/j.ejca.2023.113389_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.24516","article-title":"Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit","volume":"115","author":"van Bommel","year":"2017","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2023.113389_bib31","first-page":"1","article-title":"30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?","volume":"4","author":"Burgers","year":"2018","journal-title":"ERJ Open Res [Internet]"},{"issue":"6","key":"10.1016\/j.ejca.2023.113389_bib32","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.3390\/curroncol28060375","article-title":"Acute care use by breast cancer patients on adjuvant chemotherapy in alberta: demonstrating the importance of measurement to improving quality","volume":"28","author":"Wu","year":"2021","journal-title":"Curr Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2023.113389_bib33","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/cncr.30804","article-title":"Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer","volume":"123","author":"Powis","year":"2017","journal-title":"Cancer [Internet]"},{"key":"10.1016\/j.ejca.2023.113389_bib34","first-page":"191","article-title":"Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: a national population-based evaluation","author":"Boyle","year":"2022","journal-title":"Eur J Cancer [Internet]"},{"issue":"9","key":"10.1016\/j.ejca.2023.113389_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1470-2045(16)30383-7","article-title":"30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study","volume":"17","author":"Wallington","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00404-019-05185-x","article-title":"Recommendation of adjuvant trastuzumab treatment in HER-2-positive breast cancer patients: insights from quality indicator data collected in certified breast cancer centers in Germany, Italy, Austria, and Switzerland","volume":"300","author":"Inwald","year":"2019","journal-title":"Arch Gynecol Obstet [Internet]"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.breast.2014.11.014","article-title":"Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases","volume":"24","author":"Kowalski","year":"2015","journal-title":"Breast [Internet]"},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/intqhc\/mzv109","article-title":"Quality evaluation of medical care for breast cancer in Japan","volume":"28","author":"Mukai","year":"2016","journal-title":"Int J Qual Heal Care"},{"key":"10.1016\/j.ejca.2023.113389_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.breast.2016.07.004","article-title":"Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: a multi-institutional Portuguese cohort study","volume":"29","author":"Ferreira","year":"2016","journal-title":"Breast [Internet]"},{"issue":"5","key":"10.1016\/j.ejca.2023.113389_bib40","first-page":"1","article-title":"Breast cancer care quality in South Africa\u2019s public health system: an evaluation using American Society of Clinical Oncology\/national Quality Forum Measures","volume":"2019","author":"O\u2019Neil","year":"2019","journal-title":"J Glob Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2023.113389_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.mlr.0000135820.44720.89","article-title":"Treatment and referral patterns for colorectal cancer","volume":"42","author":"Oliveria","year":"2004","journal-title":"Med Care [Internet]"},{"key":"10.1016\/j.ejca.2023.113389_bib42","unstructured":"World Health Organisation. Cancer [Internet]; 2022. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer\u3009\u00a0(accessed\u00a0November\u00a010,\u00a02022)."},{"key":"10.1016\/j.ejca.2023.113389_bib43","unstructured":"The Society of Gynecologic Oncology. SGO clinical practice statement: genetic testing for ovarian cancer (SGO, October 2014) [Internet]; 2014. \u3008https:\/\/www.sgo.org\/resources\/genetic-testing-for-ovarian-cancer\/\u3009\u00a0(accessed\u00a0November\u00a010,\u00a02022)."},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib44","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1186\/s12913-020-05753-x","article-title":"Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries","volume":"20","author":"Ricci-Cabello","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med [Internet]"},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1751-0759-4-14","article-title":"Lessons learned in the development of process quality indicators for cancer care in Japan","volume":"4","author":"Higashi","year":"2010","journal-title":"Biopsychosoc Med [Internet]"},{"key":"10.1016\/j.ejca.2023.113389_bib47","series-title":"The definition of quality and approaches to its assessment","author":"Donabedian","year":"1980"},{"issue":"1","key":"10.1016\/j.ejca.2023.113389_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007107.pub2","article-title":"Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy","author":"Herbst","year":"2009","journal-title":"Cochrane database Syst Rev"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/jmrs.421","article-title":"A review of the barriers to using Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs) in routine cancer care","volume":"68","author":"Nguyen","year":"2021","journal-title":"J Med Radiat Sci"},{"issue":"5","key":"10.1016\/j.ejca.2023.113389_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1197\/jamia.M2667","article-title":"The effect of electronic prescribing on medication errors and adverse drug events: a systematic review","volume":"15","author":"Ammenwerth","year":"2008","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"10.1016\/j.ejca.2023.113389_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmjqs-2019-010206","article-title":"Economic analysis of the prevalence and clinical and economic burden of medication error in England","volume":"30","author":"Elliott","year":"2021","journal-title":"BMJ Qual Saf"},{"issue":"8","key":"10.1016\/j.ejca.2023.113389_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.6004\/jnccn.2016.0103","article-title":"NCCN framework for resource stratification: a framework for providing and improving global quality oncology care","volume":"14","author":"Carlson","year":"2016","journal-title":"J Natl Compr Cancer Netw [Internet]"},{"key":"10.1016\/j.ejca.2023.113389_bib53","unstructured":"World Health Organisation. Substandard and falsified medical products [Internet]; 2018. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products\u3009\u00a0(accessed\u00a0November 28,\u00a02022)."},{"key":"10.1016\/j.ejca.2023.113389_bib54","unstructured":"American Society of Clinical Oncology. Quality oncology practice initiative [Internet]; 2023.\u00a0\u3008https:\/\/practice.asco.org\/quality-improvement\/quality-programs\/quality-oncology-practice-initiative\u3009\u00a0(accessed\u00a0April 1,\u00a02023)."},{"key":"10.1016\/j.ejca.2023.113389_bib55","unstructured":"German Cancer Society. About European Cancer Centres [Internet]; 2023. \u3008https:\/\/ecc-cert.org\/european-cancer-centre\/european-cancer-centre-certification-programm\/\u3009\u00a0(accessed\u00a0April 1,\u00a02023)."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923006913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923006913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:42:58Z","timestamp":1760733778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923006913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"alternative-id":["S0959804923006913"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113389","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113389"}}